Management of the Unknown Primary Carcinoma of the Head and Neck



Management of the Unknown Primary Carcinoma of the Head and Neck


Umamaheswar Duvvuri



INTRODUCTION

Many patients with squamous cell carcinoma of the head and neck (SCCHN) present with metastasis to the cervical lymph nodes. Of these, patients with metastatic carcinoma in the cervical lymph nodes, generally excluding the supraclavicular region without an identifiable primary cancer, are defined as patients who harbor a squamous cell carcinoma of the head and neck of unknown primary origin (SCCHNUP). Patients with isolated supraclavicular metastatic carcinoma usually have a primary source from the skin or infraclavicular areas (breast, lung, esophagus, and ovary), entities that are not described here. Retrospective studies suggest that SCCHNUP is a relatively rare disease, affecting between 1% and 3% of new cases of SCCHN. These patients provide a particularly challenging clinical problem to the head and neck surgeon, and thorough physical examination and evaluation are necessary to identify the site of the primary tumor.

Patients who present with SCCHNUP can be treated either with surgery, followed by adjuvant treatment, or with primary nonsurgical therapy. However, the identification of a primary site is enormously helpful in better defining the targeted areas for radiation therapy and provide more accurate staging and prognostic information for these patients. This chapter delineates the evaluation and management of patients with squamous cell carcinoma (SCC) metastatic to the neck from an unknown primary and provides new insights into the application of transoral robotic technologies for the treatment and diagnosis of patients with SCCHN of unknown primary of the head and neck.





PHYSICAL EXAMINATION

A thorough examination of the head and neck is mandatory in all patients who present with occult lymph node metastasis. The physical examination should include palpation of the neck to determine whether the lymph nodes are fixed to underlying structures or if it is freely mobile. Palpation should also include examination of the thyroid and tracheal regions, as well as the nodal lymphatic basins of levels I through VI. Many cases of SCCHNUP are initially diagnosed by excision of a mass in the neck, which is ultimately confirmed to be SCCHN. In these patients, the physical examination can be challenging, since postsurgical scarring and induration can impact palpation and examination of the residual cervical lymph nodes. An examination of the oral cavity and oropharynx should be performed, ideally with indirect mirror laryngoscopy to examine the base of tongue (BOT) and tonsil fossae. Bimanual palpation of the BOT and tonsil fossae is also required. The physical examination should also include a careful evaluation of the cutaneous structures of the head and neck, since previously treated primary malignancies of the skin can present with isolated metastatic SCC. It should be noted that a prior history of skin cancer or skin excisions should also be included, and physical stigmata of prior skin resections, such as scars or liquid nitrogen-induced cryoablation, should also be documented.

Once this portion of the physical examination is concluded, these patients should all be examined with a flexible fiberoptic nasopharyngolaryngoscopy. This provides a better view of the BOT, tonsil fossae, glottis, hypopharynx, and supraglottic structures. It is important to evaluate the mobility of the vocal fold and look for areas of salivary pooling or submucosal masses in the postcricoid area. The nasopharynx should also be examined to exclude the possibility of a nasopharyngeal carcinoma.




CONTRAINDICATIONS

There are no contraindications to surgery based on anatomic factors. However, patients who have significant medical comorbidities that may preclude the administration of general anesthesia may not be candidates for surgery. Those patients who have a demonstrable primary cancer that appears deeply invasive on preoperative imaging do not require robotic surgery to identify the primary cancer.


PREOPERATIVE PLANNING


Radiographic Imaging

Computed tomography (CT) and/or magnetic resonance imaging (MRI) with contrast is generally considered to be the first-line imaging for patients with SCCHN metastatic to the neck from an unknown primary. If the CT and MRI do not identify the primary tumor, a positron emission tomography with integrated CT (PET/CT) may be useful. If a PET/CT scan is performed it should be performed before panendoscopy, since the biopsies or surgical interventions may in fact induce FDG (18-Flouro-DeoxyGlucose) avidity on the PET/CT scan, which could be a false positive. PET/CT scanning has been shown to identify approximately 25% of cancers that were not detected after an evaluation that did not include PET.


Laboratory Studies

Even with an extensive investigation and thorough physical examination, a primary cancer may not be found. New diagnostic procedures can potentially aid in the identification of the primary cancer or at least suggest a subsite from which the primary cancer could have arisen. Detection of HPV or Epstein-Barr virus (EBV) in the fine needle aspiration from a metastatic lymph node may be useful and may provide prognostic information.

The majority of primary cancers that are identified among patients with SCCHN of unknown primary are located within the oropharynx. Furthermore, recent studies suggest that a large percentage (up to 70%) of SCCs of the oropharynx are HPV related, and only a small percentage of cancers from nonoropharyngeal head and neck sites are HPV related. Therefore, histologic detection of HPV within tissue biopsies from the lymph node strongly suggests that the oropharynx is the source of the primary cancer. Immunohistochemical analysis of p16 is a valuable biomarker and can identify those cancers that are associated with HPV infection. HPV in situ hybridization also provides confirmatory data that validate HPV etiology.


EBV is also a sensitive marker for carcinoma of the nasopharynx, and positivity on lymph node aspirates for EBV strongly suggests the nasopharynx as the source. It should be noted that nasopharyngeal carcinomas typically metastasize to the posterior neck, level 5; and isolated level 5 nodal metastases in a patient should raise the index of suspicion for an occult primary NPC. However, it should be noted that despite the relatively high frequency of HPV- and EBV-positive cancers of the oropharynx and nasopharynx, respectively, a negative result does not necessary exclude the oropharynx or nasopharynx as the source of the primary cancer. Therefore, a complete physical examination is still mandated for all patients with SCCHNUP.


SURGICAL TECHNIQUE

Patients in whom the unknown primary cancer remains occult despite having a tonsillectomy and directed biopsies of the BOT may benefit from a robotic BOT resection to identify the primary cancer. It should be noted that these patients typically have HPV-related cancers, and the surgeon should have a high index of suspicion for a primary cancer in the oropharynx. The overall goal of the robotic BOT resection procedure is to use an en bloc resection approach under high magnification to remove all lingual tonsil tissue from the inferior portion of Waldeyer ring in order to identify the primary cancer.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 15, 2016 | Posted by in OTOLARYNGOLOGY | Comments Off on Management of the Unknown Primary Carcinoma of the Head and Neck

Full access? Get Clinical Tree

Get Clinical Tree app for offline access